We are an R&D company that comprehensively fights mycoplasma infectious disease (MID)
The mechanical and physiological properties of mycoplasma have made its detection challenging.
Recent studies have shown that mycoplasma is not merely a "cold", but is also directly linked to a variety of conditions. Conditions previously thought to be unrelated such as rheumatism, heart disease, and neurological disease appear to manifest as a result of mycoplasma infections
Our patented technology is able to identify, analyze and synthesize the antigen present on the surface membrane of mycoplasma.
We are developing "MID Prism", to monitor the disease. We aim to further develop this platform for vaccine development and disease treatment.
info@mbiotechnology.com
Company Details
- Employees
- 1
- Founded
- -
- Address
- 1-8-15 Inohana, Chuo-Ku, Chiba University Inohana Innovation Plaza # 206,japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.mbiotechnology.com
- HQ
- Chiba-shi, Chiba
M Bio Technology Inc Questions
M Bio Technology Inc's website is http://www.mbiotechnology.com
M Bio Technology Inc's LinkedIn profile is https://jp.linkedin.com/company/mbiotechnology
M Bio Technology Inc has
1 employees.
View email and phone details for 1
employees at M Bio Technology Inc.
M Bio Technology Inc's industry is
Biotechnology Research
M Bio Technology Inc's top competitors are
Ixgene Inc.,
Setsuro Tech Inc.,
Innomea Gmbh,
Quantdetect, Inc.,
Induniv,
Biofund Therapeutic Strategies,
Scivax Life Sciences, Inc.,
Inscinstech Co., Ltd.,
Crestecbio,
Proteobridge Corporation.
M Bio Technology Inc's categories are Biotechnology Research
M Bio Technology Inc's founding year is 2005
